Senior Director, Corporate Legal Affairs

How will your role help us transform hope into reality?

The Senior Director, Corporate Legal Affairs will use their understanding of securities law and corporate governance, the biopharmaceutical industry, and Blueprint Medicines business to provide pragmatic legal advice that advances the companys business and protects the companys interests. Reporting to the VP, Corporate Legal Affairs, you will have the opportunity to directly contribute to the companys success by partnering with teams in the United States and Europe on a broad range of matters, including SEC and Nasdaq reporting and compliance, equity programs, capital markets and business development activities, and external communications. This opening offers the opportunity to work in a dynamic environment where initiative, creative thinking and teamwork are valued!

What will you do?

• Handle SEC and Nasdaq reporting and compliance, including drafting 10-K, 10-Q, 8-K, S-3, S-8, annual meeting, and Section 16 filings.
• Partner with cross-functional teams to review press releases, scripts, medical meeting materials, social media postings, website content, webinar materials, publications and other external and internal communications and participate in disclosure committee meetings.
• Assist with strategic transactions, including capital markets and business development activities.
• Provide advice and guidance to the Finance, Human Resources and international teams related to equity incentive programs, insider trading policies and procedures, and other matters.
• Assist with materials for the board of directors and its committees, including drafting resolutions and minutes, and attend meetings according to business needs.
• Conduct employee onboarding and refresher training related to public company status (e.g., insider trading, individual reporting requirements) and other matters.
• Help ensure compliance, consistency, and accuracy in connection with promotional materials, disease awareness materials, publications, medical meeting materials, field force training materials, advisory boards, and market research.
• Act as a department representative on company initiatives, as assigned.
• Maintain a solid understanding of applicable laws, regulations, and enforcement actions to identify emerging risks, keep teams advised, and implement or revise policies and training programs, as appropriate.
• This position may require periodic domestic and international travel.

What minimum qualifications do we require?

• J.D. from an accredited law school
• Good standing in the Massachusetts bar
• 10+ years of legal experience in the biotechnology industry at a large law firm and/or in an in-house legal department

What additional qualifications will make you a stronger candidate?

• Thorough understanding of securities laws and regulations and corporate governance matters
• Sound judgment, high integrity, and dedication to ethical conduct
• Excellent analytical, written, and verbal communication skills
• Prior experience as a member of an in-house legal department of a biopharmaceutical company strongly preferred
• Prior experience with collaboration, licensing, and acquisition agreements in the biotechnology industry
• Prior experience advising on advertising and promotional matters for commercial biopharmaceutical companies a plus
• Ability to communicate with colleagues at all levels of the organization with both the self-confidence necessary to set forth opinions even in the face of contrary views and the humility needed to be receptive to the ideas and opinions of others
• Demonstrated ability to think strategically and pay close attention to detail
• Strong project management skills and ability to multi-task and problem-solve in a fast-paced environment while still meeting high quality and timeliness standards
• Self-motivated and independent team member who constantly seeks, designs, and implements improvements
• Ability to manage outside counsel effectively and efficiently (on the limited occasions when used) and adhere to a budget
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to [email protected].

For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement.

Blueprint Medicines is a fully integrated, commercial-stage, global biopharmaceutical company that invents life-changing medicines in two core, strategic areas of allergy/inflammation and oncology/hematology. We pursue discovery, development, and commercialization of therapies that potently and selectively target known drivers of disease, with focused investment in therapeutic areas where we can leverage our core expertise and business infrastructure to bring scale to our science. We are bringing an approved medicine to people living with systemic mastocytosis (SM) in the U.S. and Europe. Additionally, we have a pipeline of research and development programs that range from early science to advanced clinical trials in mast cell-mediated diseases, including SM and chronic urticaria, breast cancer, and other solid tumors vulnerable to CDK2 inhibition.

#LI-Hybrid

#LI-AQ1